Skip to main content

Register to vote Register by 18 June to vote in the General Election on 4 July.

  1. Home
  2. Health and social care
  3. Medicines, medical devices
  4. Vigilance, safety alerts and guidance
  5. Alerts and recalls

Drug Safety Update

From:
Medicines and Healthcare products Regulatory Agency

108 updates

108 updates
About Respiratory disease and allergy
  • Pseudoephedrine and ephedrine: nasal decongestants

    How to reduce risk of illicit use.

    • Therapeutic area: Ear, nose and throat and 1 others
    • Published:
  • Long-acting β-agonists: use in chronic obstructive pulmonary disease

    Overall benefits of long-acting β-agonists (LABAs) in the treatment of chronic obstructive pulmonary disease (COPD) continue to outweigh any risks.

    • Therapeutic area: Respiratory disease and allergy
    • Published:
  • Over-the-counter cough and cold medicines for children

    Advice on how to use cough and cold medicines safely for children under 12 years.

    • Therapeutic area: Paediatrics and neonatology and 1 others
    • Published:
  • Inhaled medicines containing corticosteroid

    Licensed doses and differences in potency between different inhaled corticosteroids; advice for use with spacer device.

    • Therapeutic area: Respiratory disease and allergy
    • Published:
  • Review on long-acting β2 agonists for asthma

    Long-acting β2 agonists (LABA) should only be prescribed in conjunction with inhaled corticosteroids for the treatment of moderate to severe asthma.

    • Therapeutic area: Respiratory disease and allergy
    • Published:
  • Talc for pleurodesis: adverse effects

    We have recently advised that talc preparations for pleurodesis are to be considered as medicinal products.

    • Therapeutic area: Respiratory disease and allergy
    • Published:
  • Ecoflac infusion solutions: risk of air embolism

    To avoid the risk of air embolism, these products should not be infused under pressure.

    • Therapeutic area: Anaesthesia and intensive care and 22 others
    • Published:
  • Inhaled corticosteroids: pneumonia

    Physicians should remain vigilant for pneumonia and other infections of the lower respiratory tract (ie, bronchitis) in patients with chronic obstructive pulmonary disease who are treated with inhaled products that contain s…

    • Therapeutic area: Respiratory disease and allergy
    • Published: